---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-071065"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2023-12-18T23:59:59+00:00"
generated_at: "2026-06-07T11:24:54.481975+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Renalytix repays $1.06M of convertible bond via 2.5M shares and $600k cash; remaining principal $13.78M

## Summary
- Repayment of $1.06M principal and interest due Jan 7, 2024 using 2.5M ordinary shares and $600k cash.
- After settlement, remaining convertible bond principal reduced to $13.78M from $14.84M.
- 2.5M new ordinary shares admitted to AIM on December 21, 2023; total voting rights become 99,930,156.
- Shares issued under Section 3(a)(9) exemption; no registration required.

## SEC filing metadata
- accession: 0000950170-23-071065
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2023-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017023071065/0000950170-23-071065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017023071065/rnlx-20231215.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-071065
- JSON: https://secwatch.observer/filing/0000950170-23-071065.json
- Plain text: https://secwatch.observer/filing/0000950170-23-071065.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.